HER2 Status Prediction on TCGA-BRCA internal cohort
95.76AUC (%)MKD (Ours)
Evaluation Results
| Method | Links | |||
|---|---|---|---|---|
| MKD (Ours)Modality=Multi-modal2025.08 | 95.76 | 92.48 | 76.88 | |
| MCATModality=Multi-modal2025.08 | 93.1 | 84.96 | 65.06 | |
| PorpoiseModality=Multi-modal2025.08 | 92.8 | 89.65 | 68.94 | |
| CMTAModality=Multi-modal2025.08 | 92.03 | 87.94 | 66.55 | |
| MKD (Ours)Modality=Pathology2025.08 | 74.56 | 81.56 | 39.1 | |
| TDCModality=Pathology2025.08 | 72.86 | 77.87 | 42.87 | |
| ABMILModality=Pathology2025.08 | 72.13 | 77.3 | 39.36 | |
| DTFDModality=Pathology2025.08 | 70.72 | 75.88 | 40.18 | |
| CLAMModality=Pathology2025.08 | 70.51 | 80.56 | 37.13 | |
| GEEModality=Pathology2025.08 | 70.06 | 74.6 | 41.32 | |
| DAMLNModality=Pathology2025.08 | 69.92 | 84.53 | 22.37 | |
| WIKGModality=Pathology2025.08 | 68.5 | 74.89 | 38.3 | |
| RRTModality=Pathology2025.08 | 68.08 | 77.44 | 28.13 | |
| TransMILModality=Pathology2025.08 | 66.23 | 75.6 | 33.45 |